Hepatic arterial embolization for metastatic hormone‐secreting tumors technique, effectiveness, and complications

Richard Marlink, Jacob J. Lokich, Jerrold R. Robins, Melvin E. Clouse

Research output: Contribution to journalArticle

72 Scopus citations

Abstract

Ten patients with hepatic metastases from islet cell tumors or carcinoid tumors had clinical symptoms from hormonal secretion and/or pain related to the mass effect of neoplastic liver involvement. Hepatic arterial embolization (HAE) using radiographically guided catheters to inject thrombogenic material was applied to the right and/or left hepatic arteries separately 5 to 7 days apart. All ten patients improved within days of the procedure as confirmed by a decrease in measurable hormone levels (gastrin, adrenocorticotropin, and 5‐hydroxy indole acetic acid) or by a decrease in tumor size and improved symptoms. Three patients underwent repeated reembolization from two to four times over nine to 50‐month intervals for symptom control. Complications of and indications for HAE in these patients are discussed. It appears to be an effective treatment for dealing with the hormonal syndromes and local symptoms related to the hepatic metastases of hormone‐secreting tumors.

Original languageEnglish (US)
Pages (from-to)2227-2232
Number of pages6
JournalCancer
Volume65
Issue number10
DOIs
StatePublished - Jan 1 1990
Externally publishedYes

    Fingerprint

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this